Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction
- 1 September 1998
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 136 (3) , 398-405
- https://doi.org/10.1016/s0002-8703(98)70212-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor ExpressionJournal of Cardiovascular Pharmacology, 1997
- Hemostatic Changes After Dietary Coenzyme Q10 Supplementation in SwineJournal of Cardiovascular Pharmacology, 1996
- Time course of platelet alpha granule release in acute myocardial infarction treated with streptokinase.Heart, 1996
- Flow cytometry reveals activated GP IIb???IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarctionBlood Coagulation & Fibrinolysis, 1995
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Flow Cytometric Measurement of Platelet Function and Reticulated PlateletsAnnals of the New York Academy of Sciences, 1993
- Enhanced platelet function in acute myocardial infarction is attenuated by streptokinase treatmentJournal of Internal Medicine, 1992
- Platelet function after in vivo and in vitro treatment with thrombolytic agentsThe American Journal of Cardiology, 1992
- Platelet function and conjugated diene concentrations in diabetic and non-diabetic survivors of acute myocardial infarctionCardiovascular Research, 1991
- Plasmin inhibition of platelet function and of arachidonic acid metabolism.Journal of Clinical Investigation, 1985